Thomas Haselhorst

Associate Professor Thomas Haselhorst is a research leader at the Institute for Biomedicine and Glycomics, Griffith University, with a distinguished career in structural glycoscience and NMR spectroscopy. His expertise spans glycan-virus interactions, structure-guided drug design, and targeted drug delivery for diseases like SARS-CoV-2, HIV, and Non-Hodgkin’s Lymphoma. He has pioneered NMR methodologies to study glycan-cell receptor dynamics and developed glycan-based prebiotics to reduce Campylobacter jejuni in poultry.

• Education:
  • Doctor of Natural Science (Dr rer nat), Medical University Lübeck (1996-1999)
• Research Interests:
  • Structural analysis of glycan-pathogen interactions
  • Design of prebiotic supplements for agricultural applications
  • Development of glycan-targeted therapies for viral and fungal diseases
  • Innovative NMR approaches for ligand-binding studies
• Article Trends:
  • Focus on glycan-virus binding mechanisms (SARS-CoV-2, Influenza, Rotavirus)
  • Structural characterization of antifungal and anticancer agents
  • Methodological advancements in NMR-based glycan analysis
  • Exploration of glycan-glycan crosslinking in disease
• Scientific Awards:
  • ARC Future Fellow
  • Alexander von Humboldt Fellow
• Supervision:
  • Principal/Associate Supervisor for 15+ doctoral students
  • Research on glycan roles in HIV, cancer, and pathogenic fungi
• Collaborative Networks:
  • International partnerships in glycomics and virology
  • Multi-million-dollar grants from ARC, NHMRC, and industry